William Blair Weighs in on Zoetis Inc’s Q1 2018 Earnings (ZTS)

Zoetis Inc (NYSE:ZTS) – Stock analysts at William Blair boosted their Q1 2018 earnings estimates for shares of Zoetis in a report released on Thursday. William Blair analyst J. Kreger now forecasts that the company will post earnings of $0.69 per share for the quarter, up from their previous forecast of $0.62. William Blair also issued estimates for Zoetis’ Q2 2018 earnings at $0.72 EPS, Q3 2018 earnings at $0.79 EPS, Q4 2018 earnings at $0.79 EPS, FY2018 earnings at $3.00 EPS, FY2019 earnings at $3.31 EPS and FY2021 earnings at $4.01 EPS.

Zoetis (NYSE:ZTS) last posted its earnings results on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.02. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.32 billion. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The company’s revenue was up 8.5% on a year-over-year basis. During the same quarter last year, the company earned $0.52 earnings per share.

Other equities analysts have also recently issued research reports about the stock. Cantor Fitzgerald set a $85.00 price objective on shares of Zoetis and gave the company a “buy” rating in a research note on Thursday. BidaskClub cut shares of Zoetis from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, September 20th. BMO Capital Markets boosted their price objective on shares of Zoetis from $65.00 to $70.00 and gave the company a “market perform” rating in a research note on Friday, November 3rd. Zacks Investment Research cut shares of Zoetis from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $65.00 price objective on shares of Zoetis in a research note on Tuesday, October 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $71.28.

Zoetis (ZTS) opened at $75.39 on Friday. The company has a market cap of $36,740.00, a P/E ratio of 39.68, a P/E/G ratio of 1.88 and a beta of 1.06. Zoetis has a 12 month low of $52.00 and a 12 month high of $75.69. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80.

A number of institutional investors have recently made changes to their positions in the business. BlackRock Inc. lifted its position in Zoetis by 3.9% during the second quarter. BlackRock Inc. now owns 37,495,299 shares of the company’s stock valued at $2,338,957,000 after purchasing an additional 1,412,829 shares during the last quarter. Vanguard Group Inc. lifted its position in Zoetis by 2.8% during the second quarter. Vanguard Group Inc. now owns 33,654,686 shares of the company’s stock valued at $2,099,379,000 after purchasing an additional 910,265 shares during the last quarter. Janus Henderson Group PLC lifted its position in Zoetis by 1.5% during the third quarter. Janus Henderson Group PLC now owns 5,893,853 shares of the company’s stock valued at $375,792,000 after purchasing an additional 84,767 shares during the last quarter. Northern Trust Corp lifted its position in Zoetis by 1.2% during the second quarter. Northern Trust Corp now owns 5,533,313 shares of the company’s stock valued at $345,168,000 after purchasing an additional 63,849 shares during the last quarter. Finally, Legal & General Group Plc lifted its position in Zoetis by 1.5% during the third quarter. Legal & General Group Plc now owns 2,400,106 shares of the company’s stock valued at $153,025,000 after purchasing an additional 34,747 shares during the last quarter. Institutional investors and hedge funds own 93.19% of the company’s stock.

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 1st. Shareholders of record on Friday, January 19th will be given a dividend of $0.126 per share. The ex-dividend date of this dividend is Thursday, January 18th. This is a positive change from Zoetis’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a yield of 0.67%. Zoetis’s payout ratio is presently 22.11%.

COPYRIGHT VIOLATION NOTICE: This article was published by Stock Observer and is owned by of Stock Observer. If you are reading this article on another website, it was stolen and reposted in violation of international trademark and copyright laws. The correct version of this article can be accessed at https://www.thestockobserver.com/2018/01/13/william-blair-weighs-in-on-zoetis-incs-q1-2018-earnings-zts.html.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Earnings History and Estimates for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply